[Abstract Only] Randomized Trial: Single Dose of Ivermectine Preferred over Multiple Doses for Non-disseminated Strongyloidiasis
4 Oct, 2019 | 07:13h | UTCMultiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)
Related Commentary on Twitter
New online: Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial https://t.co/ZGXvtA5Hps
— The Lancet Infectious Diseases (@TheLancetInfDis) September 24, 2019